US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Biodesix, Inc. - Common Stock (NQ:BDSX)

26.02 +0.39 (+1.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4 ↗
Biodesix Inc. reported strong Q4 performance, with significant revenue growth. 
Via Talk Markets
News headline image
Biodesix: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Biodesix to Participate in Two Investor Conferences in June
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
News headline image
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 ↗
BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix's Earnings Outlook ↗
 
Via Benzinga
News headline image
Recap: Biodesix Q3 Earnings ↗
 
Via Benzinga
News headline image
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
News headline image
S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26% to 16,251.98. The... 
Via Benzinga
Topics Stocks
News headline image
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. 
Via Benzinga
News headline image
Gold Surges Over 1%; Biodesix Shares Plummet ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 1.01% to 38,987.23 while the NASDAQ rose 1.50% to 16,289.37. The... 
Via Benzinga
Topics Stocks
News headline image
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded up 0.30% to 38,713.29 while the NASDAQ rose 0.35%... 
Via Benzinga
Topics Economy Stocks
News headline image
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
From Biodesix, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2024 ↗
Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly loss at $0.28 per share on revenue of $71.72 million. 
Via Benzinga
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
From Biodesix, Inc.
Via Business Wire
News headline image
3 Penny Stocks to Turn $999 Into $1 Million: January 2024 ↗
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets. 
Via InvestorPlace
Topics Economy
News headline image
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Participate in Two Upcoming Investor Conferences in November
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix Announces Third Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
From Biodesix, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >